Neuroinflammation in COVID‐19 and ADRD: Similarities, differences, and interactions. (1st February 2022)

• Record Type: Journal Article
• Authors: Concha, Rachel; Ohayon, Elan; Lam, Ann
• Is Part Of: Alzheimer's & dementia. Volume 17(2021)Supplement 3
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-02-01
• Subjects: Alzheimer's disease -- Periodicals; Alzheimer Disease -- Periodicals; Dementia -- Periodicals; Démence; Maladie d'Alzheimer; Périodique électronique (Descripteur de forme); Ressource Internet (Descripteur de forme); 616.83
• DOI: 10.1002/alz.056282
• Languages: English
• ISSNs: 1552-5260

Abstract

Abstract: Background: The severe acute respiratory syndrome coronavirus 2 (SARS‐COV‐2) causes various neurological manifestations including neuroinflammation. Neuroinflammation is also present in Alzheimer's Disease and Related Dementias (ADRD). Despite the widespread and devastating impact of these conditions, the full causal mechanisms leading to neuroinflammation and its impact on outcomes remain elusive. Here we examine neuroinflammation in COVID‐19 and ADRD in order to identify similarities, differences and interactions that could aid in addressing the biopsychosocial mechanisms and consequences in both conditions. Method: Using an expanded Adverse Outcome Pathway (AOP) approach we constructed a framework to compare the similarities and differences in key events leading to neuroinflammation. The framework is based on a meta‐survey of the literature as well as existing AOPs. Key findings were assessed for similarities and differences regarding the clinical presentation, biological mechanisms, risk, protective factors, and treatment interventions. Additionally, we considered health disparities that may contribute to the worsening progression of both COVID‐19 and ADRD. Result: The comparison and intersections of COVID‐19 and ADRD show various overlapping factors across scales. An overlap of immune system and inflammatory processes exacerbate both conditions, potentially leading to increased mortality rates. Although there are major differences in the initiating events, timelines and molecular cascades, there are significant pathway commonalities across scales. Furthermore, commonalities in underlying conditions, such as obesity, Type 2 diabetes, cardiovascular disease, hypertension, and metabolic disorders, are major risk factors in both COVID‐19 and ADRD, which worsen the outcomes. Additionally, lifestyle risk factors, such as poor nutrition, physical inactivity and cognitive status, may further exacerbate the deadly prognosis for both conditions. Conclusion: Given the crucial role of inflammation and immune system functioning in both these conditions, implementing preventative measures to strengthen the immune system and decrease comorbid conditions and lifestyle risk factors is imperative, especially for vulnerable populations. Mapping approaches such as AOPs can be particularly helpful in evaluating the weight of current evidence and knowledge gaps in a rapidly evolving scientific data landscape, such as the COVID‐19 pandemic. These approaches can also serve as a foundation to further probe the complexities of multiscale interactions in diseases that may otherwise initially appear unrelated.